Skip to content
Canli Capital

Research

FX Carry + Trend Overlay (the real construction): a killed candidate

Verdict: KILLED Stage: screen prototype
Identity: fx_carry_trend_overlay

The professional FX book: trend hedges carry's crashes. It screened at 0.32 — but the robustness stress-test killed it. The Sharpe SPIKED only at the exact threshold we picked by hand (a knob artifact, ~0.15 on either side); it died at realistic cost (25x turnover, 0.05 at 5bp); ALL the performance came from one post-2021 regime; and dropping JPY collapsed it to -0.07 — the entire 'edge' was the single short-JPY trade. Not a diversified premium. KILLED on robustness, before we built a thing.

Why it was worth testing

This died at the screen stage, before a full walk-forward was ever run. Screening exists so that ideas which cannot clear a coarse, cost-aware bar do not consume the far more expensive machinery behind it. A screen kill is a cheap kill, and it is published for the same reason as an expensive one: the trial was still spent, and it still raises the evidence bar for everything already in the book.

The result

Measure Value
Screen net Sharpe 0.3200

What this does and does not say

It says this configuration, on this data, net of the costs we charge, did not clear the bar it pre-registered. It does not say the underlying economic effect does not exist, that no implementation of it works, or that someone with different data or different execution would reach the same conclusion. A null is evidence about a test, not a proof about a market.

It also does not say the trial was free. Every hypothesis tested raises the deflated-Sharpe hurdle for every sleeve already in the book, including the ones that survived. That is why the kill count is published beside the survivor count rather than behind it.